Aircraft Mounts Industry size is expected to register 8.1% CAGR between 2025 and 2034 propelled by growing awareness of the health benefits.Selbyville, Delaware , Jan. 29, 2025 (GLOBE NEWSWIRE) -- Aircraft Mounts Market was valued at USD 886.5 million in 2024 and is projected to be worth USD 1.9 billion by the end of 2034, as per a recent study by Global Market Insights Inc. The aviation sector has been expanding rapidly, driven by a rise in global air travel demand. As the middle class grows, especially i ...

Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Oncology NGS Market: Analysis By Technology, By Workflow, By Application, By End User, By Region Size and Trends - Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. The global oncology NGS market value in 2023 stood at US$510.76 million, and is projected to reach US$1.16 billion by 2029. The global oncology NGS market value is projected to grow at a CAGR of 14.76%, during the forecast period of 2024-2029.The global oncology NGS m ...

China Emerging Key Player in Development Of Gamma Delta T Cell Cancer Therapy Says KUICK RESEARCHDelhi, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Global Gamma Delta T Cell Cancer Therapy Market Opportunity and Clinical Trials Insight 2030 Report Conclusions: Number Of Gamma Delta T Cell Therapies In Trials: > 30 TherapiesUS & China Dominating Clinical Trials Landscape: > 20 TherapiesGlobal Gamma Delta T Cell Therapy Clinical Trials Insight By Company, Country, Indication and PhaseGamma Delta T Cell Therapy Future M ...

Securities Issuance and Stabilisation - Engineering Ingegneria Informatica S P A is issuing EUR fixed rate notes due 2030 and EUR FRN notes due 20230 with the offer price to be announced [3] - The stabilisation period is expected to start on 29 January 2025 and end no later than 12 March 2025 [3] - The Stabilisation Managers include BNP Paribas UBS and other joint bookrunners such as B Akros BPM Cacib DB Intesa GS Nomura and Unicredit [3] - The Stabilisation Managers may over-allot the securities to support the market price during the stabilisation period [3] Regulatory and Jurisdictional Information - The announcement is not an offer of securities for sale into the United States and the securities are not registered under the United States Securities Act of 1933 [8] - The announcement is directed at persons outside the United Kingdom and qualified investors in the UK or EEA Member States [5][7]

Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Top 7 Growth Opportunities in Smart Homes, 2025" report has been added to ResearchAndMarkets.com's offering.This study delves into the smart homes market with insightful analysis of near-future trends that will shape and drive its growth in 2025. This study presents the top 7 trends in the smart homes market. It revisits and reviews 2024's top 5 growth opportunities and includes 2 new trends that will collectively impact the smart homes ecosystem in 2025. Smar ...

Industry Overview - Targeted alpha therapy (TAT) has emerged as a groundbreaking treatment for cancer, utilizing alpha-emitting isotopes to deliver highly localized radiation to tumor cells while minimizing damage to healthy tissues [2] - The short range of alpha particles allows for concentrated radiation delivery to cancerous cells, even in low quantities, making TAT particularly beneficial for challenging cancers [2] - TAT has gained significant traction in recent years, supported by extensive research highlighting its potential in treating both hematological and solid tumors [2] Key Milestones - The FDA's approval of Xofigo (radium Ra-223 dichloride) in 2013 marked a pivotal advancement for TAT, specifically for advanced prostate cancer with bone metastases [3] - Xofigo's success has catalyzed further research into TAT for various cancer types, including solid tumors and hematological malignancies [3] Clinical Developments - Over 20 targeted alpha therapies are currently in clinical trials, with researchers focusing on specific tumor markers like PSMA in prostate cancer and CD38 in multiple myeloma [4] - Memorial Sloan Kettering Cancer Center is developing [225Ac]Ac-Macropa-PEG-Isatuximab, a CD38-targeted alpha therapy for multiple myeloma, showing significant tumor burden reduction and delayed progression in preclinical studies [4] - Hematological malignancies such as CLL and non-Hodgkin's lymphoma are also being explored for TAT, with anti-CD37-targeted therapies like 212Pb-NNV003 showing promising preclinical results [5] Commercial Landscape - TAT has created a thriving market for pharmaceutical companies and research institutions, attracting significant investments for developing new alpha-emitting radiopharmaceuticals [6] - Actinium Pharmaceuticals is conducting clinical trials, such as the LIN-AC225-AML02 trial, combining Actimab-A and venetoclax for treating acute myeloid leukemia (AML), with promising preliminary results [6] Future Prospects - TAT's potential to revolutionize cancer treatment lies in its ability to deliver potent alpha radiation directly to tumor cells with precision unattainable by traditional radiation therapies [7] - Continuous advancements in isotope production, molecular targeting, and imaging technologies are expected to broaden TAT's application across various cancer types, offering more precise and individualized treatment options [7][8]

Transaction Details - Kaspi kz completed the acquisition of 40 000 000 Class A and 173 246 220 Class B shares of Hepsiburada representing 65 41% of the total outstanding share capital of Hepsiburada [1][7] - The total consideration for the shares was approximately $1 127 million with $600 million paid in cash on the Closing Date and $526 9 million of Deferred Cash Consideration to be paid within six months [7] - Kaspi kz pledged 65 199 658 Class B shares of Hepsiburada as collateral for the Deferred Cash Consideration [7] Strategic Rationale - The acquisition expands Kaspi kz's addressable market to 100 million people aligning with its strategic priority [2] - The combined knowledge and technology of Kaspi kz and Hepsiburada will drive fast and sustainable bottom-line growth [3] - The partnership aims to advance ecommerce and digital services in Türkiye and Kazakhstan benefiting SMEs and entrepreneurs in both countries [4] Management Commentary - Mikheil Lomtadze CEO of Kaspi kz emphasized the focus on profitable growth and leveraging combined expertise for future success [3] - Hanzade Doğan Founder of Hepsiburada highlighted the alignment with Kaspi kz's mission of sustainable growth and value creation [5] Company Overview - Kaspi kz operates a unique two-sided Super App model with 14 million MAU in 2023 and 581 thousand merchant partners [8][9] - The company's Super Apps provide access to Payments Marketplace and Fintech Platforms designed to meet everyday needs [10] - Kaspi kz's business model combines a highly engaged user base best-in-class digital products and a capex lite approach resulting in strong top-line growth and profitability [11]

The European surgical robotics simulation market is expanding rapidly as healthcare systems adopt advanced technologies to improve surgical training and patient outcomes. Surgeons can practice procedures using robotic systems in a virtual environment through surgical robotics simulation, which offers risk-free, realistic training to improve skills and lower medical errors. European Surgical Robotics Simulation Market European Surgical Robotics Simulation Market Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- T ...

Amid intensified weed resistance challenges, trifluralin commands attention through targeted efficacy and established protocols. Enhanced formulations, collaborative research, and promising field results catalyze steady market growth across diverse agricultural landscapesNew Delhi, Jan. 29, 2025 (GLOBE NEWSWIRE) -- According to recent analysis conducted by Astute Analytica, the North America trifluralin market was valued at US$ 67.46 million in 2024 and is anticipated to reach US$ 101.21 million by 2033, at ...

The research report on power-to-X market states that the proliferating demand for green hydrogen and other forms of green energy among industries, corporations, and organizations are the major sources that gain traction for the market. Thus, the advanced technology that converts or transforms one type of energy into another has become prevalent.NEWARK, Del, Jan. 29, 2025 (GLOBE NEWSWIRE) -- According to a Future Market Insights (FMI), the global power-to-X market is gaining unprecedented momentum as economi ...